Cancer Innovation

ISSN 2770-9191 e-ISSN 2770-9183 CN 10-1951/R73

Editor-in-Chief: Fei Ma

Open Access

Articles & Issues

Advanced Search

Keyword: tyrosine kinase inhibitor

Search in: this journal | the platform

Open Access Commentary

Pooled analyses of randomized controlled trials on pyrotinib plus capecitabine and a rethink of the first‐line options for HER2‐positive relapsed or metastatic breast cancer

Xiuwen Guan, Fei Ma, Binghe Xu

https://doi.org/10.1002/cai2.21

Published: 14 July 2022

2022, 1 (2): 119-123

Downloads: 50 | Views: 796 |

total 1